Registration
AVANIR PHARMACEUTICALS for AVANIR PHARMACEUTICALS
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical Research and Development, Post-Acute Care Reform, Central Nervous System Disorders, Patent Reform, FDA Reform, FDA Approval Pathways, Medicare/Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CHRISTINE D'ORSIE New | Director of Advocacy |
| CRYSTAL LYNN VANUCH New | Head of Government Affairs |
Pharmacy PHA
Pharmaceutical Research and Development, Post-Acute Care Reform, Central Nervous System Disorders, Patent Reform, FDA Reform, FDA Approval Pathways, Medicare/Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CHRISTINE D'ORSIE New | Director of Advocacy |
| CRYSTAL LYNN VANUCH New | Head of Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.